Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pavol, Slavik"'
Autor:
Erik Kudela, Karol Kajo, Erik Kozubik, Tomas Rokos, Terezia Pribulova, Jan Danko, Eva Kudelova, Igor Homola, Pavol Slavik, Barbora Macurova, Kamil Biringer
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast. They have a proliferating stromal component that can be graded as benign, borderline, and malignant. In addition, they are associated with an increased risk of local recurrence
Externí odkaz:
https://doaj.org/article/d8625fe3564e4b08a9a6acae0049af86
Autor:
Barbora Váňová, Pavol Slavik, Alenka Líšková, Karla Scheerova, Dusan Loderer, Zora Lasabova, Ivana Kasubova, Marian Grendar, Anna Farkasova, Marek Samec, Katarína Janíková, Zuzana Dankova, Lukáš Plank
Publikováno v:
Neoplasma. 68:1107-1112
Ovarian cancer is the leading cause of mortality among all gynecological cancers in developed countries and its most common and most lethal type is the high-grade serous ovarian carcinoma (HGSC). At the molecular level, nearly half of all HGSCs exhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2871143d3b0806074eb7d5778e7e0a55
https://doi.org/10.4149/neo_2021_210226n256
https://doi.org/10.4149/neo_2021_210226n256
Autor:
Mangesh Bhide, Eduard Goffa, Lukáš Plank, Dana Jurkovicova, Božena Smolková, Ľudovít Kulcsár, Pavol Slavik, Michal Mego, Katarína Lešková, Michal Kalman, Peter Bujdak, Lucia Pulzova, Ján Kliment, Jan Roska, Miroslav Chovanec
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5573, p 5573 (2021)
Volume 13
Issue 21
Cancers, Vol 13, Iss 5573, p 5573 (2021)
Volume 13
Issue 21
Simple Summary For clinical stage I (CS I) seminoma patients, management through the risk-adapted strategy with adjuvant carboplatin-based chemotherapy in the presence of risk factors and surveillance in the absence of these factors is the preferred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed5aa3c939e17406353c6b100b0d72a
http://europepmc.org/articles/PMC8583098
http://europepmc.org/articles/PMC8583098
Autor:
Kamil Biringer, Pavol Slavik, Tomas Rokos, Jan Danko, Terezia Pribulova, Karol Kajo, Igor Homola, Barbora Macurova, Eva Kudelova, Erik Kozubik, Erik Kudela
Publikováno v:
Case Reports in Obstetrics and Gynecology
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast. They have a proliferating stromal component that can be graded as benign, borderline, and malignant. In addition, they are associated with an increased risk of local recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e800ac216ae63020d81f5fdac4ed1ec1
http://europepmc.org/articles/PMC8390174
http://europepmc.org/articles/PMC8390174
Autor:
Erik, Kozubík, Terézia, Pribulová, Tomáš, Rokos, Erik, Kudela, Pavol, Slavik, Kamil, Biringer
Publikováno v:
Neuro endocrinology letters. 42(3)
Cervical cancer (CC) is one of the most common cancers of the female reproductive system. In advanced stages, it might lead to metastases via hematogenous or lymphatic spread. Patients with hematogenous metastases are less common with a higher risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d502c8b4549fd52d5f1a47f031c1e0e
https://pubmed.ncbi.nlm.nih.gov/34279858
https://pubmed.ncbi.nlm.nih.gov/34279858
Publikováno v:
Pathology - Research and Practice. 213:295-300
Survivin is the smallest member of the inhibitors of apoptosis (IAP) family. However, participation in inhibition of apoptosis is not the only function of this molecule. Survivin can also affect the proper process of mitosis and even promoting of ang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d62b16ce0f8aa6453f158faadd280b
https://doi.org/10.1016/j.prp.2017.02.009
https://doi.org/10.1016/j.prp.2017.02.009
Autor:
Jana Sivakova, Pavol Buocik, Pavol Slavik, Erik Kudela, Jan Danko, Lukáš Plank, Petra Sumichrastova, Jozef Visnovsky
Publikováno v:
Cancer Treatment Communications. 2:12-15
Objective To report a rare case of cervical malignancy necessitating complex treatment. Case A sixty-five year old woman was admitted to the hospital with a diagnosed tumor arising from the upper lip of the cervix. Patient underwent the amputation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2a73332a57bf8a8f8e2a0856d2cc61
https://doi.org/10.1016/j.ctrc.2014.02.001
https://doi.org/10.1016/j.ctrc.2014.02.001
Autor:
Ivan Damjanov, Milan Hora, Petr Martinek, Pavol Slavik, Michal Michal, Ondrej Hes, Stela Bulimbasic, Barbora Gomolčáková, Fredrik Petersson
Publikováno v:
Annals of Diagnostic Pathology. 16:459-469
Only a few cases of sarcomatoid renal cell carcinomas (RCCs) with squamous differentiation have been published. We present 2 RCCs exhibiting a hitherto not reported biphasic neoplastic cell population exhibiting a predominantly alveolar architecture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5e3718336c06e7ca346fe3ff66ca28
https://doi.org/10.1016/j.anndiagpath.2012.08.007
https://doi.org/10.1016/j.anndiagpath.2012.08.007
Autor:
Jozef, Visnovsky, Erik, Kudela, Pavol, Slavik, Milan, Krkoska, Pavol, Buocik, Peter, Szepe, Jan, Danko
Publikováno v:
Neuro endocrinology letters. 36(8)
Uterine sarcomas are rare mesodermal malignant tumors with an incidence between 0.5 and 3.3 cases per 100,000 females per year. Most sarcomas are aggressive tumors leading to poor overall survival rates and only limited therapeutic options. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c977f955b5d88e72e3559338afa0144e
https://pubmed.ncbi.nlm.nih.gov/26921575
https://pubmed.ncbi.nlm.nih.gov/26921575
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 36(9)
Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. The former ones are common gynecological diseases, whereas malignant mesenchymal tumors, which behave in a much more aggressive way, are quit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba841e5bb536ba53ae4db45d775f4e3
https://pubmed.ncbi.nlm.nih.gov/26307392
https://pubmed.ncbi.nlm.nih.gov/26307392